Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,330 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis.
Kitade M, Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Shirai Y, Yamazaki M, Uemura M, Yamao J, Fujimoto M, Mitoro A, Toyohara M, Sawai M, Yoshida M, Morioka C, Tsujimoto T, Kawaratani H, Fukui H. Kitade M, et al. Among authors: shirai y. World J Gastroenterol. 2009 Nov 7;15(41):5193-9. doi: 10.3748/wjg.15.5193. World J Gastroenterol. 2009. PMID: 19891019 Free PMC article.
Attenuation of insulin-resistance-based hepatocarcinogenesis and angiogenesis by combined treatment with branched-chain amino acids and angiotensin-converting enzyme inhibitor in obese diabetic rats.
Yoshiji H, Noguchi R, Kaji K, Ikenaka Y, Shirai Y, Namisaki T, Kitade M, Tsujimoto T, Kawaratani H, Fukui H. Yoshiji H, et al. Among authors: shirai y. J Gastroenterol. 2010 Apr;45(4):443-50. doi: 10.1007/s00535-009-0158-z. Epub 2009 Nov 26. J Gastroenterol. 2010. PMID: 19941011
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats.
Kaji K, Yoshiji H, Kitade M, Ikenaka Y, Noguchi R, Shirai Y, Aihara Y, Namisaki T, Yoshii J, Yanase K, Tsujimoto T, Kawaratani H, Fukui H. Kaji K, et al. Among authors: shirai y. Am J Physiol Gastrointest Liver Physiol. 2011 Jun;300(6):G1094-104. doi: 10.1152/ajpgi.00365.2010. Epub 2011 Mar 3. Am J Physiol Gastrointest Liver Physiol. 2011. PMID: 21372165 Free article.
Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat.
Yoshiji H, Noguchi R, Ikenaka Y, Namisaki T, Kitade M, Kaji K, Shirai Y, Yoshii J, Yanase K, Yamazaki M, Tsujimoto T, Kawaratani H, Akahane T, Aihara Y, Fukui H. Yoshiji H, et al. Among authors: shirai y. BMC Res Notes. 2009 May 5;2:70. doi: 10.1186/1756-0500-2-70. BMC Res Notes. 2009. PMID: 19416517 Free PMC article.
1,330 results